Inactief instrument

Andere talen Cyclacel Pharmaceuticals Inc Nasdaq

Aandelen

US23254L3069

slotkoers Nasdaq Andere beurzen
- ^USD	-

30/04	Top Middag Gainers	MT
30/04	Exchange-Traded Funds, aandelenfutures dinsdag lager voorafgaand aan de FOMC-vergadering	MT

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

Cyclacel Pharmaceuticals, Inc. announced that it has received $8.000001 million in funding	02/05
Top Midday Gainers	30/04
Exchange-Traded Funds, Equity Futures Lower Pre-Bell Tuesday Ahead of FOMC Meeting	30/04
Cyclacel Pharmaceuticals, Inc. announced that it expects to receive $8.000001 million in funding	30/04
Cyclacel Pharmaceuticals Withdraws Securities Offering SEC Filing	29/04
Cyclacel Pharmaceuticals : April 2024 Corporate Presentation	02/04
Cyclacel Pharmaceuticals to Present New Clinical Data at 2024 ASCO Annual Meeting Highlighting Fadraciclib's Potential as a Precision Medicine for Cancer	01/04
Cyclacel Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update	20/03
Earnings Flash (CYCC) CYCLACEL Posts Q4 Revenue $31,000	19/03
Cyclacel Pharmaceuticals, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	19/03
Cyclacel Pharmaceuticals, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	19/03
Cyclacel Pharmaceuticals Announces Preclinical Proof-of-Concept Data for Fadraciclib to be presented at the American Association for Cancer Research Annual Meeting 2024	08/03
Cyclacel Pharmaceuticals Announces Receipt of $2.9 Million R&D Tax Credit	07/03
Cyclacel Pharmaceuticals to Participate in 2024 BIO CEO and Investor Conference	21/02
Cyclacel Pharmaceuticals Announces the Appointment of Brian Schwartz, M.D. as Chief Medical Officer	31/01
Cyclacel Pharmaceuticals, Inc. Announces Board Changes	30/01
Cyclacel Pharmaceuticals, Inc. Announces Executive Changes	30/01
Top Premarket Gainers	08/01
Cyclacel Pharmaceuticals to Present at Biotech Showcase 2024	03/01
Cyclacel Pharmaceuticals, Inc. announced that it expects to receive $0.026374 million in funding	22/12

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Cyclacel Pharmaceuticals Inc Nasdaq

Aandelen

US23254L3069

Andere talen

Filters